Presentation is loading. Please wait.

Presentation is loading. Please wait.

FIGURE 1 Predicted risk of NTDs by RBC folate concentrations by folic acid source among nonpregnant women aged 12–49 ... FIGURE 1 Predicted risk of NTDs.

Published byΛευί Λαγός Modified over 5 years ago

Similar presentations

Presentation on theme: "FIGURE 1 Predicted risk of NTDs by RBC folate concentrations by folic acid source among nonpregnant women aged 12–49 ... FIGURE 1 Predicted risk of NTDs."— Presentation transcript:

1 FIGURE 1 Predicted risk of NTDs by RBC folate concentrations by folic acid source among nonpregnant women aged 12–49 ... FIGURE 1 Predicted risk of NTDs by RBC folate concentrations by folic acid source among nonpregnant women aged 12–49 y, NHANES, 2007–2012. y axis: median NTD prevalence and 95% uncertainty intervals were predicted based on RBC folate concentrations obtained from previously reported associations between RBC folate concentrations and NTD prevalence (18) at the 5th–95th percentile stratified by source of folic acid intake: ECGP only, ECGP + RTE, ECGP + SUP, and all 3 sources ECGP + RTE + SUP. z axis: RBC folate concentrations at the 5th–95th percentile by source of folic acid. EGCP, enriched cereal grain product; NTD, neural tube defect; RBC, red blood cell; RTE, ready-to-eat cereal; SUP, supplement containing folic acid. Unless provided in the caption above, the following copyright applies to the content of this slide: © 2018 American Society for Nutrition.This work is written by (a) US Government employee(s) and is in the public domain in the US. Am J Clin Nutr, Volume 107, Issue 6, 14 May 2018, Pages 1027–1034, The content of this slide may be subject to copyright: please see the slide notes for details.

Download ppt "FIGURE 1 Predicted risk of NTDs by RBC folate concentrations by folic acid source among nonpregnant women aged 12–49 ... FIGURE 1 Predicted risk of NTDs."

Similar presentations

FIGURE 1 HEI-2015 total mean scores and 95% CIs for children aged 2–18 y by age group (n = 2372, 2- to 5-y-olds; n = 3347, 6- to 11-y-olds; n = 3281, 12-

FIGURE 1 HEI-2015 total mean scores and 95% CIs for children aged 2–18 y by age group (n = 2372, 2- to 5-y-olds; n = 3347, 6- to 11-y-olds; n = 3281, 12-
Figure 1 Overall lag-cumulative exposure–response relationships between air temperature and myocardial infarction ... Figure 1 Overall lag-cumulative exposure–response.

Figure 1 Overall lag-cumulative exposure–response relationships between air temperature and myocardial infarction ... Figure 1 Overall lag-cumulative exposure–response.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
FIGURE 1 Distribution of total body iron (calculated from serum ferritin and soluble transferrin receptor ... FIGURE 1 Distribution of total body iron.

FIGURE 1 Distribution of total body iron (calculated from serum ferritin and soluble transferrin receptor ... FIGURE 1 Distribution of total body iron.
FIGURE 1 Association of habitual coffee intake with incident of CVD in the UK Biobank and in an earlier meta-analysis ... FIGURE 1 Association of habitual.

FIGURE 1 Association of habitual coffee intake with incident of CVD in the UK Biobank and in an earlier meta-analysis ... FIGURE 1 Association of habitual.
Figure 1 Approximate timeline contrasting major historical events in the understanding of ulcerative colitis (red) and ... Figure 1 Approximate timeline.

Figure 1 Approximate timeline contrasting major historical events in the understanding of ulcerative colitis (red) and ... Figure 1 Approximate timeline.
Figure 1 Data-selection process

Figure 1 Data-selection process
Figure 1 Flow diagram detailing the systematic review process.

Figure 1 Flow diagram detailing the systematic review process.
Figure 1 Schematic representation of the experimental design.

Figure 1 Schematic representation of the experimental design.
Figure 1 Mechanism of mortality benefit associated with radial access

Figure 1 Mechanism of mortality benefit associated with radial access
FIGURE 1 Percentage of patients with sarcopenia or low SMD across the spectrum of total adiposity (N = 3262). SMD, ... FIGURE 1 Percentage of patients.

FIGURE 1 Percentage of patients with sarcopenia or low SMD across the spectrum of total adiposity (N = 3262). SMD, ... FIGURE 1 Percentage of patients.
FIGURE 1 PRISMA flow diagram of studies in systematic review

FIGURE 1 PRISMA flow diagram of studies in systematic review
FIGURE 1 Patient enrolment flowchart. SBS, short bowel syndrome.

FIGURE 1 Patient enrolment flowchart. SBS, short bowel syndrome.
Folic acid food fortification to prevent neural tube defects

Folic acid food fortification to prevent neural tube defects
FIGURE 1 Flowchart of the study population.

FIGURE 1 Flowchart of the study population.
FIGURE 3 Incidence of anemia by WDDS category at baseline and endpoint

FIGURE 3 Incidence of anemia by WDDS category at baseline and endpoint
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
AHA: American Heart Association; ALT: ...

AHA: American Heart Association; ALT: ...
Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.

Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.
Source: Figure created by the author based on data ...

Source: Figure created by the author based on data ...

Similar presentations

Ads by Google